Sistemik Juvenil İdiyopatik Artrit

Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390-392.

Still GF. On a Form of Chronic Joint Disease in Children. MedChir Trans. 1897; 80:47-60.9.

Sağ E, Uzunoğlu B, Bal F, et al. Systemic onset juvenile idiopathic arthritis: a single center experience. Turk J Pediatr. 2019;61(6):852-858. doi:10.24953/turkjped.2019.06.005

Shenoi S, Horneff G, Cidon M, et al. The burden of systemic juvenile idiopathic arthritis for patients and care givers: an international survey and retrospective chart review. Clin Exp Rheumatol. 2018;36(5):920-928.

Singh-Grewal D, Schneider R, Bayer N, et al. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum. 2006;54(5):1595-1601. doi:10.1002/art.21774

Lovell DJ, Passo M, Giannini E, et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol. 2001;28(1):220.

Zaripova LN, Midgley A, Christmas SE, et al. Juvenile idiopathic arthritis: from a etiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J. 2021;19(1):135. Published 2021 Aug 23. doi:10.1186/s12969-021-00629-8

Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. NatRevRheumatol. 2011;7(7):416-426. Published 2011 Jun 7. doi:10.1038/nrrheum.2011.68

De Benedetti F, Martini A. Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis? Arthritis Rheum. 2005;52(3):687-693. doi:10.1002/art.20946

Pascual V, Allantaz F, Arce E, et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J ExpMed. 2005;201(9):1479-1486. doi:10.1084/jem.20050473

Frosch M, Ahlmann M, Vogl T, et al. Themyeloid-relatedproteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60(3):883-891. doi:10.1002/art.24349

Behrens EM, Beukelman T, Gallo L, et al. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008;35(2):343-348.

Schneider R, Lang BA, Reilly BJ, et al. Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthritis. J Pediatr. 1992;120(2 Pt 1):200-205. doi:10.1016/s0022-3476(05)80427-5

Kimura Y, Vastert SJ. Systemic Juvenile Idiopathic Arthritis. In: Petty RE, Laxer RM, Lindsley CB, et al. eds. Textbook of Pediatric Rheumatology (8th ed). Philadelphia: Elsevier, 2021: 216-227.

Prendiville JS, Tucker LB, Cabral DA,et al. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset still disease or systemic juvenile idiopathic arthritis sine arthritis? Pediatr Dermatol. 2004;21(5):580-588. doi:10.1111/j.0736-8046.2004.21513.x

Demir F, Sözeri B. Jüvenil idiopatik artrit patogenezi ve klinik bulgular. Sözeri B, editör. Çocukluk Çağında Her Yönüyle Otoimmün Romatizmal Hastalıklar. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.9-15.

Ramanan AV, Wynn RF, Kelsey A, et al. Systemic juvenile idiopathic arthritis, Kikuchi's disease and haemophagocytic lymphohistiocytosis- is there a link? Case report and literatüre review. Rheumatology (Oxford). 2003;42(4):596-598. doi:10.1093/rheumatology/keg167

Baszis KW, Singh G, White A, et al. Recurrent cardiac tamponade in a child with newly diagnosed systemic-onset juvenile idiopathicarthritis. J Clin Rheumatol. 2012;18(6):304-306. doi:10.1097/RHU.0b013e3182685857

Kimura Y, Weiss JE, Haroldson KL, et al. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013;65(5):745-752. doi:10.1002/acr.21889

Schulert GS, Yasin S, Carey B, et al. Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors. Arthritis Rheumatol. 2019;71(11):1943-1954. doi:10.1002/art.41073

Saper VE, Chen G, Deutsch GH, et al. Emergent high fatality lung disease in systemic juvenile arthritis [published correctionappears in Ann RheumDis. 2022 Feb;81(2):e35]. Ann RheumDis. 2019;78(12):1722-1731. doi:10.1136/annrheumdis-2019-216040

Binstadt BA, Levine JC, Nigrovic PA, et al. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis. Pediatrics. 2005;116(1):e89-e93. doi:10.1542/peds.2004-2190

Dong S, Bout-Tabaku S, Texter K, et al. Diagnosis of systemic-onset juvenile idiopathic arthritis after treatment for presumed Kawasaki disease. J Pediatr. 2015;166(5):1283-1288. doi:10.1016/j.jpeds.2015.02.003

Minoia F, Davì S, Horne A, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multi center study of 362 patients. Arthritis Rheumatol. 2014;66(11):3160-3169. doi:10.1002/art.38802

Silverman ED, Miller JJ, Bernstein B, et al. Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr. 1983;103(6):872-876. doi:10.1016/s0022-3476(83)80704-5

Ravelli A, Minoia F, Davì S, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/PaediatricRheumatology International Trials Organisation Collaborative Initiative. ArthritisRheumatol. 2016;68(3):566-576. doi:10.1002/art.39332

DeWitt EM, Kimura Y, Beukelman T, et al. Consensus treatment plans for new-onsetsystemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2012;64(7):1001-1010. doi:10.1002/acr.21625

Cush JJ, Medsger TA Jr, Christy WC, et al. Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum. 1987;30(2):186-194. doi:10.1002/art.1780300209

Gorelik M, Fall N, Altaye M, et al. Follistatin-like protein 1 and the ferritin/erythrocyte sedimentation rate ratio are potential biomarkers for dysregulated gene expression and macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2013;40(7):1191-1199. doi:10.3899/jrheum.121131

Nigrovic PA. Review: is there a window of opportunity fo rtreatment of systemic juvenile idiopathic arthritis? ArthritisRheumatol. 2014;66(6):1405-1413. doi:10.1002/art.38615

Lang BA, Schneider R, Reilly BJ, et al. Radiologic features of systemiconset juvenile rheumatoid arthritis. J Rheumatol. 1995;22(1):168-173.

Oen K, Reed M, Malleson PN, et al. Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J Rheumatol. 2003;30(4):832-840.

Ünsal ŞE, Kasapçopur Ö. Juvenil İdiopatik Artrit. In:Poyrazoğlu MH, Sözeri B, eds. Romatoloji Kitabı (1. baskı).Ankara, Güneş Tıp Kitabevi, 2018: 95-118

Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporo mandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2022;74(4):521-537. doi:10.1002/acr.24853

Köker O, Aktay Ayaz N. Jüvenil idiopatik artrit tedavi ve izlemi. Sözeri B, editör. Çocukluk Çağında Her Yönüyle Otoimmün Romatizmal Hastalıklar. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.16-26.

Lomater C, Gerloni V, Gattinara M, et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol. 2000;27(2):491-496.

Calabro JJ, Holgerson WB, Sonpal GM, et al. Juvenile rheumatoid arthritis: a general review and report of 100 patients observed for 15 years. Semin Arthritis Rheum. 1976;5(3):257-298. doi:10.1016/0049-0172(76)90027-5

Fantini F, Gerloni V, Gattinara M, et al. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. J Rheumatol. 2003;30(3):579-584.

Spiegel LR, Schneider R, Lang BA. et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis:a multicenter cohort study. Arthritis Rheum. 2000;43(11):2402-2409.doi:10.1002/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C

Modesto C, Woo P, García-Consuegra J, et al. Systemic onset juvenile chronic arthritis, poly articular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol. 2001;19(2):211-217.

Sandborg C, Holmes TH, Lee T, et al. Candidate early predictors for progression to joint damage in systemic juvenile idiopathicarthritis. J Rheumatol. 2006;33(11):2322-2329.

Russo RA, Katsicas MM. Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome. J Rheumatol. 2013;40(3):329-334. doi:10.3899/jrheum.120386

Hashkes PJ, Wright BM, Lauer MS, et al. Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum. 2010;62(2):599-608. doi:10.1002/art.27218